Why BGPT?
logo

Evidence Paper Review

Analyze how experimental results and claims are presented, scoped, and limited in a paper.Know what the science actually supports before you trust the answer.

Press Enter ↡ to analyze


     Quick Answer



    Key finding (host RNA-seq)
    In BALB/c mouse brains at 32 days post–Toxoplasma gondii PLK infection, the study reports 935 upregulated vs 12 downregulated host genes, with upregulated pathways dominated by immune responses / antigen presentation / cell activation and downregulated genes enriched for small-GTPase signaling, vesicle-mediated transport, and cation transport.



     Long Answer



    Paper review: Transcriptome Analysis of Mouse Brain Infected with Toxoplasma gondii
    Tanaka et al., Infection and Immunity (2013). DOI: 10.1128/iai.00439-13
    Claimed biological thrust: parasite burden is associated with a host shift toward immune/activation programs and away from neuronal function-linked gene sets; clinical-sign vs asymptomatic infected animals show additional transcriptional differences.
    Primary evidence in the paper: host RNA-seq (TopHat + Cufflinks + DESeq + GOstat) on whole brain at 32 dpi; histopathology scoring; parasite quantification by qPCR (B1 gene).
    1) Visualize the core result: DE genes (host brain, 32 dpi)
    Interpretation: the global picture is strongly skewed toward induced immune/activation programs rather than broad suppression. However, because β€œdownregulated” is only 12 genes by their exact threshold, downstream mechanistic emphasis should be proportionate to effect evidence and not over-weight β€œfew-gene” suppression narratives.
    2) Read mapping quality: mapped reads to mouse genome
    Interpretation: mapping percentages range roughly from ~63% to ~85% across libraries. That is not β€œideal perfect,” but it is plausible for RNA-seq of heterogeneous brain tissue. What matters for differential expression is consistent processing and appropriate normalization; the paper reports Cufflinks normalization and DESeq-based differential testing.
    3) Parasite burden vs clinical sign (the paper’s small cohort)
    Interpretation (with skepticism): parasite burden increases monotonically across the paper’s labeled severity categories in this tiny set of 5 infected animals (7.22 β†’ 26.98). But with N=5 and severity based on clinical observation categories, correlation strength is suggestive rather than definitive. The strongest claims in the paper are better interpreted as β€œassociated with parasite number” rather than causal.
    4) Enrichment logic: immune vs neuronal-function-linked GO terms (directional)
    The paper’s narrative splits host gene responses into two β€œdirections”:
    • Positive correlation with parasite numbers: immune system processes / antigen presentation (GOstat on positively correlated genes).
    • Negative correlation with parasite numbers: small-GTPase-mediated signaling and vesicle-mediated transport, plus cation transport (GOstat on negatively correlated genes).
    Important skeptical caveat: GO-term enrichment on correlation-selected gene lists is not the same as demonstrating that neuronal signal transduction is functionally impaired; it demonstrates that mRNA abundance changes (or absence of expression) trend in those biological-process annotations as parasite burden varies. Cell-type composition changes (more infiltrating immune cells, microglial activation, etc.) can also drive β€œneuronal-function” gene downtrends.
    5) Clinical-sign differential expression: Irf4, Tgfbi, Egr4
    Mechanistic speculation control: the paper proposes links between these genes and immune/neurobiological changes, but in this review we treat them as statistically reported expression differences, not proven causal mediators.
    6) Critical quality review (what’s strong vs what’s fragile)
    Strengths (evidence-backed)
    • Multi-modal triangulation: histopathology scoring, parasite burden quantification by qPCR (B1 gene), and RNA-seq are integrated in the same study design.
    • Clear statistical thresholds: the DE criteria are specified (2-fold and FDR<0.05), and GOstat uses Benjamini correction with FDR<0.05.
    Fragilities / red flags (methodological skepticism)
    • Small effective N for RNA-seq: 4 uninfected and 5 infected libraries were used for RNA-seq differential expression. With modest N, fold-change+FDR filtering can still yield unstable gene lists (especially for borderline genes).
    • Correlation β‰  mechanism: negative correlations between parasite burden and neuronal-process GO terms could reflect cell-composition shifts (e.g., more microglia/immune cells) rather than intrinsic downregulation in neurons. The paper itself acknowledges that β€œfurther experiments are needed to understand what kinds of cells express the genes.”
    • Bulk tissue RNA-seq: whole-brain RNA-seq mixes neurons, glia, infiltrating immune cells, and region-dependent parasite distributions. Without cell-type deconvolution or single-cell resolution, β€œneuronal dysfunction” inferences remain probabilistic.
    • Downregulated gene list is tiny (12): emphasizing neurological mechanisms from a small downregulated set can be fragile unless validated. The paper focuses mainly on GO terms enriched among negatively correlated genes rather than simply the 12 downregulated DE genes.
    • No parasite transcript reads separated: the pipeline aligns reads to mouse genome and reports mapped reads to mm10. The analysis therefore emphasizes host transcripts; it cannot directly quantify parasite transcriptional programs in the same RNA-seq experiment (unless unmapped reads are further analyzed, which is not described here).
    Where the paper is scientifically useful anyway
    • Hypothesis generator: it provides concrete gene-set directions (immune/antigen presentation up with burden; vesicle/small-GTPase/cation transport down with burden) that can be prioritized for validation and mechanistic cell-type studies.
    • Clinical-sign subset: the Irf4/Tgfbi/Egr4 expression differences are a starting point for β€œdisease sign” stratification in future transcriptome studies.
    Jump to author-specific BGPT reviews
    These links open BGPT author-focused review pages for each full-name author identified in the provided paper text.


    Feedback:    

    Updated: April 30, 2026



     BGPT Paper Review



    Study Novelty

    60%

    The study applies standard host RNA-seq differential expression + GO enrichment to a well-known pathogen–brain context, producing a specific immune-versus-neuronal-process transcriptomic split and parasite-burden correlations, but it is not a fundamentally new methodology or conceptual leap beyond typical infection transcriptome profiling in that era. (Novelty is driven mainly by the specific PLK/BALB/c 32-day design and the gene-set directions reported.)



    Scientific Quality

    70%

    Scientific quality is moderate-to-good: clear experimental framing and specified analysis thresholds; multi-modal measurements (parasite load + histopathology + host RNA-seq) support internal consistency. Main reproducibility/strength limitations are small RNA-seq N (4 vs 5), bulk-tissue inference without cell-type resolution, and mechanistic claims that remain correlative (especially for β€œneuronal dysfunction”).



    Study Generality

    50%

    The results are potentially generalizable in broad strokes (infection-associated neuroinflammation and antigen presentation signatures are plausible across models), but the specific gene lists and correlation patterns likely depend on strain, host background, sampling timepoint, and bulk tissue composition. The paper itself uses a specific BALB/c + PLK + 32-day design, and parasite distribution is region-dependent.



    Study Usefulness

    80%

    High usefulness as a hypothesis generator and stratification map: it provides statistically defined host immune and putative neuronal-process directions tied to parasite burden and clinical signs (Irf4/Tgfbi/Egr4). However, it does not provide cell-type resolution or functional neuronal assays to validate causality.



    Study Reproducibility

    60%

    The methods are described with key computational steps and thresholds, but the provided text does not include public accession numbers for RNA-seq data, and analysis uses older tool versions (TopHat/Cufflinks era) where exact parameters and reference builds can materially affect results. Small N further reduces reproducibility across cohorts.



    Explanatory Depth

    60%

    The paper reports statistical associations between parasite burden and host gene-expression categories but does not implement functional validation (e.g., neuronal activity measures, cell-type-specific perturbations) within the described study design, limiting mechanistic depth to transcriptomic inference.


    🎁 Authors: Collect 120 Free Science Tokens (β‰ˆ $12.0 USD)

    Claim My Author Tokens

    Use for 30 days of free BGPT access (4 tokens = 1 day) or trade/sell (β‰ˆ $12.0 USD)

     Top Data Sources ExportMCP



     Analysis Wizard



    Creates publication-faithful plots from the paper’s extracted counts and categories (DE gene numbers, mapped-read percentages, parasite burden vs clinical signs), enabling quick sanity checks of effect direction and cohort structure.



     Hypothesis Graveyard



    The simplistic idea that β€œneuronal genes are globally turned off by parasite numbers” is unlikely to be universally true in bulk RNA-seq because bulk tissue mixes cell types and parasite distribution is regional; the paper itself notes region-dependent pathology and calls for cell-type source experiments.


    A single downstream causal pathway from immune activation to vesicle-transport suppression is over-specified; current evidence is correlation-based with limited downregulated gene counts and no functional assays, so strong causal pathway selection is premature.

     Science Art


    Paper Review: Transcriptome Analysis of Mouse Brain Infected with Toxoplasma gondii Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT